Attacks on vertical mergers have been quite rare in recent years, but the FTC, at the urging of several members of Congress, appears to be taking a keen interest in the merger between retail pharmacy chain, CVS, and Caremark, a leading pharmacy benefit manager. The primary concern appears to be that the merged firm will improperly channel customers to CVS pharmacies, harming competition in the retail pharmacy industry.